Discussion
Mighty Therapeutics, a Massachusetts-based biotech company, announced that it has raised $150 million to support the clinical development of its treatment candidates for Parkinson’s disease and other neurodegenerative conditions. The new funding is expected to expedite pipeline initiatives in Parkinson’s as well as ongoing late-stage drug development programs…
